Related Experiment Video
Updated: Dec 13, 2025
08:10
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
8.1K
Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development.
Rishika Chaudhary1,2,3, Robert A H Scott4, Graham Wallace2
1Academic Unit of Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, UK.
Translational Vision Science & Technology
|August 4, 2020
Summary
Identifying predictive molecular biomarkers for proliferative vitreoretinopathy (PVR) is crucial. Current methods are limited, necessitating a broader approach to PVR biomarker discovery for better patient stratification and targeted therapies.
Area of Science:
- Ophthalmology
- Molecular Biology
- Biomarker Discovery
Background:
- Proliferative vitreoretinopathy (PVR) complicates 5%-10% of rhegmatogenous retinal detachments.
- PVR is a primary cause of retinal reattachment surgery failure.
- Existing surgical adjunctive agents for PVR prevention show limited efficacy.
Purpose of the Study:
- To identify predictive molecular biomarkers for PVR development after retinal reattachment surgery.
- To enable better patient stratification for targeted drug evaluations.
- To summarize inflammatory and fibrogenic factors in ocular fluids during PVR development.
Main Methods:
- Narrative literature review.
- Analysis of inflammatory and fibrogenic factors in ocular fluid samples.
- Evaluation of potential molecular biomarkers for PVR prediction.
Main Results:
- Few identified factors possess significant predictive biomarker value for PVR.
- A combinatorial approach and expanded phenotype of potential factors are needed.
- Understanding disease signaling pathways is key to biomarker identification.
Conclusions:
- Current biomarkers have limited predictive value for PVR.
- A broader search for PVR biomarkers is required.
- Biomarker discovery necessitates understanding PVR pathogenesis and signaling pathways.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
01:28Role of Hematopoietic Growth Factors
2.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
2.9K
01:17Gastritis-II: Pathophysiology
991
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
991
01:16Clot Retraction and Fibrinolysis
8.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.0K
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
6.8K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
6.8K